GB201906302D0 - Methods of determining the margin of a tumour - Google Patents

Methods of determining the margin of a tumour

Info

Publication number
GB201906302D0
GB201906302D0 GBGB1906302.3A GB201906302A GB201906302D0 GB 201906302 D0 GB201906302 D0 GB 201906302D0 GB 201906302 A GB201906302 A GB 201906302A GB 201906302 D0 GB201906302 D0 GB 201906302D0
Authority
GB
United Kingdom
Prior art keywords
tumour
margin
determining
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1906302.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amlo Biosciences Ltd
Original Assignee
University of Newcastle, The
Newcastle University of Upon Tyne
Amlo Biosciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Newcastle, The, Newcastle University of Upon Tyne, Amlo Biosciences Ltd filed Critical University of Newcastle, The
Priority to GBGB1906302.3A priority Critical patent/GB201906302D0/en
Publication of GB201906302D0 publication Critical patent/GB201906302D0/en
Priority to GBGB1911216.8A priority patent/GB201911216D0/en
Priority to PCT/GB2020/051091 priority patent/WO2020225547A1/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
GBGB1906302.3A 2019-05-03 2019-05-03 Methods of determining the margin of a tumour Ceased GB201906302D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB1906302.3A GB201906302D0 (en) 2019-05-03 2019-05-03 Methods of determining the margin of a tumour
GBGB1911216.8A GB201911216D0 (en) 2019-05-03 2019-08-06 Methods of determining the margin of a tumour
PCT/GB2020/051091 WO2020225547A1 (en) 2019-05-03 2020-05-01 Methods of determining the margin of a tumour

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1906302.3A GB201906302D0 (en) 2019-05-03 2019-05-03 Methods of determining the margin of a tumour

Publications (1)

Publication Number Publication Date
GB201906302D0 true GB201906302D0 (en) 2019-06-19

Family

ID=66776639

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB1906302.3A Ceased GB201906302D0 (en) 2019-05-03 2019-05-03 Methods of determining the margin of a tumour
GBGB1911216.8A Ceased GB201911216D0 (en) 2019-05-03 2019-08-06 Methods of determining the margin of a tumour

Family Applications After (1)

Application Number Title Priority Date Filing Date
GBGB1911216.8A Ceased GB201911216D0 (en) 2019-05-03 2019-08-06 Methods of determining the margin of a tumour

Country Status (2)

Country Link
GB (2) GB201906302D0 (en)
WO (1) WO2020225547A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116710475A (en) * 2020-12-15 2023-09-05 国家科学研究中心 SQSTM1 and its use in cancer therapy

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0404097A2 (en) 1989-06-22 1990-12-27 BEHRINGWERKE Aktiengesellschaft Bispecific and oligospecific, mono- and oligovalent receptors, production and applications thereof
WO1993011161A1 (en) 1991-11-25 1993-06-10 Enzon, Inc. Multivalent antigen-binding proteins
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201818618D0 (en) * 2018-11-15 2019-01-02 Amlo Biosciences Ltd Monoclonal antibodies against ambra-1

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0404097A2 (en) 1989-06-22 1990-12-27 BEHRINGWERKE Aktiengesellschaft Bispecific and oligospecific, mono- and oligovalent receptors, production and applications thereof
WO1993011161A1 (en) 1991-11-25 1993-06-10 Enzon, Inc. Multivalent antigen-binding proteins
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification

Non-Patent Citations (13)

* Cited by examiner, † Cited by third party
Title
"Pharmaceutical Excipients: Properties, Functionality and Applications in Research and Industry", vol. 72, 2002, BMJ PUBLISHING GROUP LTD AND ROYAL PHARMACEUTICAL SOCIETY
AUSUBEL ET AL.: "Current Protocols in Molecular Biology", 1990, JOHN WILEY AND SONS
BIRD ET AL., SCIENCE, vol. 242, 1988, pages 423 - 426
CHOTHIALESK, J. MOL. BIOL., vol. 196, 1987, pages 901 - 917
GREENE ET AL.: "Protective Groups in Organic Synthesis", 1999, WILEY-INTERSCIENCE
HARLOW ET AL.: "Antibodies: A Laboratory Manual", 1988, COLD SPRING HARBOR LABORATORY
HUSTON ET AL., PNAS (USA, vol. 85, 1988, pages 5879 - 5883
KATRITZKY ET AL.: "Comprehensive Heterocyclic Chemistry IF", vol. 66, 1996, PERGAMON PRESS, article "Epitope Mapping Protocols"
KOCIENSKI ET AL., PROTECTING GROUPS, 1994
SAMBROOK ET AL.: "Molecular Cloning, A Laboratory Manual", 2001, COLD HARBOR-LABORATORY PRESS
TROST ET AL.: "Comprehensive Organic Synthesis", 1991, PERGAMON
WARD ET AL., NATURE, vol. 341, 1989, pages 544 - 546
ZAPATA ET AL., PROTEIN ENG., vol. 8, no. 10, 1995, pages 1057 - 1062

Also Published As

Publication number Publication date
WO2020225547A1 (en) 2020-11-12
GB201911216D0 (en) 2019-09-18

Similar Documents

Publication Publication Date Title
GB201804255D0 (en) Macrophage-based therapy
IL279685A (en) Gene therapy
GB201900702D0 (en) Therapy
GB201819853D0 (en) Therapy
GB201907882D0 (en) Methods
GB201912191D0 (en) New therapy
GB201913716D0 (en) Methods
GB201911216D0 (en) Methods of determining the margin of a tumour
GB201906705D0 (en) Methods
GB201817470D0 (en) Gene therapy
GB201802326D0 (en) Gene therapy
GB201918752D0 (en) New therapy
GB201818579D0 (en) New therapy
GB201907157D0 (en) Methods
GB201814036D0 (en) New therapy
GB201903909D0 (en) Methods
GB201901817D0 (en) Methods
EP3760209C0 (en) Ischemic-lesion-site-specific gene therapy
GB201919036D0 (en) Therapy
GB2584407B (en) Anti-perforation panel
GB201919177D0 (en) Novel therapy
GB201916983D0 (en) Therapy
GB201914848D0 (en) Therapy
GB201913785D0 (en) Therapy
GB201913797D0 (en) Therapy

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application

Owner name: AMLO BIOSCIENCES LTD

Free format text: FORMER OWNERS: AMLO BIOSCIENCES LIMITED;UNIVERSITY OF NEWCASTLE UPON TYNE

AT Applications terminated before publication under section 16(1)